Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,782 | 99 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $573.24 | 34 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $358.96 | 18 | $0 (2023) |
| ITI, Inc. | $245.43 | 13 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $172.74 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $155.20 | 8 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $97.30 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $37.94 | 2 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $36.81 | 3 | $0 (2022) |
| Tris Pharma Inc | $33.13 | 2 | $0 (2023) |
| Lundbeck LLC | $28.87 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.58 | 1 | ABBVIE INC. ($27.58) |
| 2023 | $1,045 | 50 | ABBVIE INC. ($392.44) |
| 2022 | $709.45 | 48 | ABBVIE INC. ($153.22) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Neuropsychiatry | ||||||
| 11/28/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $136.18 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Neuroscience | ||||||
| 10/03/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Neuropsychiatry | ||||||
| 08/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Neuroscience | ||||||
| 08/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: PSYCHIATRY | ||||||
| 08/03/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: PSYCHOLOGY | ||||||
| 08/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 54 | 77 | $16,092 | $4,790 |
| 2022 | 3 | 101 | 163 | $18,990 | $10,812 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 32 | $6,740 | $1,965 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 33 | $5,902 | $1,687 | 28.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $3,450 | $1,138 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 119 | $11,900 | $6,965 | 58.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 26 | 26 | $4,200 | $2,313 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $2,890 | $1,534 | 53.1% |
About Cari Overstreet, APRN
Cari Overstreet, APRN is a Psychiatric/Mental Health healthcare provider based in Fort Smith, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2021. The National Provider Identifier (NPI) number assigned to this provider is 1912663758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cari Overstreet, APRN has received a total of $1,782 in payments from pharmaceutical and medical device companies, with $27.58 received in 2024. These payments were reported across 99 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,782).
As a Medicare-enrolled provider, Overstreet has provided services to 155 Medicare beneficiaries, totaling 240 services with total Medicare billing of $15,602. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Fort Smith, AR
- Active Since 11/16/2021
- Last Updated 05/21/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1912663758
Products in Payments
- VRAYLAR (Drug) $573.24
- INGREZZA (Drug) $358.96
- CAPLYTA (Drug) $245.43
- REXULTI (Drug) $114.65
- QUVIVIQ (Drug) $97.30
- INVEGA SUSTENNA (Drug) $89.86
- ABILIFY MAINTENA (Drug) $69.24
- SPRAVATO (Drug) $65.34
- AUSTEDO (Drug) $37.94
- HETLIOZ (Drug) $36.81
- Dyanavel XR (Drug) $33.13
- ARISTADA (Drug) $28.13
- ABILIFY ASIMTUFII (Drug) $17.72
- QELBREE (Drug) $14.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Fort Smith
Christopher Milstead, Aprn-Cnp, APRN-CNP
Psychiatric/Mental Health — Payments: $4,520
Kellie Berry-Hert, Nurse Practitioner, NURSE PRACTITIONER
Psychiatric/Mental Health — Payments: $3,913
Mrs. Kelsey Sallee, Aprn, Rn, APRN, RN
Psychiatric/Mental Health — Payments: $2,971
Carrie Poole, Aprn, APRN
Psychiatric/Mental Health — Payments: $2,449
Felicia Fuller, Aprn, APRN
Psychiatric/Mental Health — Payments: $1,708
Ms. Alice Welch, Anp, ANP
Psychiatric/Mental Health — Payments: $1,375